Smart polyhydroxyalkanoate nanobeads by protein based functionalization

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 4, 2015, Pages 885-899

  Dinjaski, Nina ^a   Prieto, M Auxiliadora ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Depolymerase; Functionalized polyhydroxyalkanoates; Granule associated proteins; Phasins; Synthase

Indexed keywords

BACTERIA; BIOPRODUCTS; DIAGNOSIS; ENZYME IMMOBILIZATION; GRANULATION; MEDICAL APPLICATIONS; NANOSTRUCTURED MATERIALS;

DEPOLYMERASE; GRANULE-ASSOCIATED PROTEINS; PHASINS; POLYHYDROXYALKANOATES; SYNTHASES;

RECOMBINANT PROTEINS;

ENDOTOXIN; NANOBEAD; NANOCARRIER; POLYHYDROXYALKANOIC ACID; RECOMBINANT PROTEIN; BACTERIAL PROTEIN; NANOPARTICLE;

BACTERIAL CELL; BIOSEPARATION; CARBON STORAGE; COVALENT BOND; ENZYME IMMOBILIZATION; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; IN VIVO STUDY; NANOBIOTECHNOLOGY; NANOTECHNOLOGY; PERSONALIZED MEDICINE; PROTEIN IMMOBILIZATION; REVIEW; SCALE UP; SYNTHESIS; WILD TYPE; CHEMISTRY; METABOLISM;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

BACTERIAL PROTEINS; GRAM-POSITIVE BACTERIA; NANOPARTICLES; POLYHYDROXYALKANOATES;

EID: 84929303294     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.01.018     Document Type: Review

References (141)

1. Rodríguez-Carmona E., Villaverde A. Nanostructured bacterial materials for innovative medicines. Trends Microbiol 2010, 18:423-430.
2. Draper J.L., Rehm B.H. Engineering bacteria to manufacture functionalized polyester beads. Bioengineered 2012, 3:203-208.
3. Panyam J., Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55:329-347.
4. Chen G.Q. A microbial polyhydroxyalkanoates (PHA) based bio- and materials industry. Chem Soc Rev 2009, 38:2434-2446.
5. Tortajada M., da Silva L.F., Prieto M.A. Second-generation functionalized medium-chain-length polyhydroxyalkanoates: the gateway to high-value bioplastic applications. Int Microbiol 2013, 16:1-15.
6. Dinjaski N., Fernández-Gutiérrez M., Selvam S., Parra-Ruiz F.J., Lehman S.M., San Román J., et al. PHACOS, a functionalized bacterial polyester with bactericidal activity against methicillin-resistant Staphylococcus aureus. Biomaterials 2014, 35:14-24.
7. Moldes C., García P., García J.L., Prieto M.A. In vivo immobilization of fusion proteins on bioplastics by the novel tag BioF. Appl Environ Microbiol 2004, 70:3205-3212.
8. Dinjaski N., Prieto M.A. Swapping of phasin modules to optimize the in vivo immobilization of proteins to medium-chain-length polyhydroxyalkanoate granules in Pseudomonas putida. Biomacromolecules 2013, 14:3285-3293.
9. Galán B., Dinjaski N., Maestro B., de Eugenio L.I., Escapa I.F., Sanz J.M., et al. Nucleoid-associated PhaF phasin drives intracellular location and segregation of polyhydroxyalkanoate granules in Pseudomonas putida KT2442. Mol Microbiol 2011, 79:402-418.
10. Jendrossek D., Pfeiffer D. New insights in formation of polyhydroxyalkanoate (PHA) granules (carbonosomes) and novel functions of poly(3-hydroxybutyrate) (PHB). Environ Microbiol 2013, 10.1111/1462-2920.12356.
11. Stanley S. Biological nanoparticles and their influence on organisms. Curr Opin Biotechnol 2014, 28:69-74.
12. Jendrossek D. Polyhydroxyalkanoate granules are complex subcellular organelles (carbonosomes). J Bacteriol 2009, 191:3195-3202.
13. Lewis J.G., Rehm B.H.J. ZZ polyester beads: an efficient and simple method for purifying IgG from mouse hybridoma supernatants. Immunol Methods 2009, 346:71-74.
14. Peters V., Rehm B.H. In vivo enzyme immobilization by use of engineered polyhydroxyalkanoate synthase. Appl Environ Microbiol 2006, 72:1777-1783.
15. Chen S.Y., Chien Y.W., Chao Y.P. In vivo immobilization of d-hydantoinase in Escherichia coli. J Biosci Bioeng 2014, 118:78-81.
16. Moldes C., Farinós G.P., de Eugenio L.I., García P., García J.L., Ortego F., et al. New tool for spreading proteins to the environment: Cry1Ab toxin immobilized to bioplastics. Appl Microbiol Biotechnol 2006, 72:88-93.
17. Blatchford P.A., Scott C., French N., Rehm B.H. Immobilization of organophosphohydrolase OpdA from Agrobacterium radiobacter by overproduction at the surface of polyester inclusions inside engineered Escherichia coli. Biotechnol Bioeng 2012, 109:1101-1108.
18. Bäckström B.T., Brockelbank J.A., Rehm B.H.A. Recombinant Escherichia coli produces tailor-made biopolyester granules for applications in fluorescence activated cell sorting: functional display of the mouse interleukin-2 and myelin oligodendrocyte glycoprotein. BMC Biotechnol 2007, 7:3.
19. Parlane N.A., Wedlock D.N., Buddle B.M., Rehm B.H. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents. Appl Environ Microbiol 2009, 75:7739-7744.
20. Grage K., Jahns A.C., Parlane N., Palanisamy R., Rasiah I.A., Atwood J.A., et al. Bacterial polyhydroxyalkanoate granules: biogenesis, structure, and potential use as nano-/micro-beads in biotechnological and biomedical applications. Biomacromolecules 2009, 10:660-669.
21. Atwood J.A., Rehm B.H. Protein engineering towards biotechnological production of bifunctional polyester beads. Biotechnol Lett 2009, 31:131-137.
22. Lee S.J., Park J.P., Park T.J., Lee S.Y., Lee S., Park J.K. Selective immobilization of fusion proteins on poly(hydroxyalkanoate) microbeads. Anal Chem 2005, 77:5755-5759.
23. Chen S., Parlane N.A., Lee J., Wedlock D.N., Buddle B.M., Rehm B.H. New skin test for detection of bovine tuberculosis on the basis of antigen-displaying polyester inclusions produced by recombinant Escherichia coli. Appl Environ Microbiol 2014, 80:2526-2535.
24. Grage K., Rehm B.H. In vivo production of scFv-displaying biopolymer beads using a self-assembly-promoting fusion partner. Bioconjug Chem 2008, 19:254-262.
25. Mifune J., Grage K., Rehm B.H. Production of functionalized biopolyester granules by recombinant Lactococcus lactis. Appl Environ Microbiol 2009, 75:4668-4675.
26. Parlane N.A., Rehm B.H., Wedlock D.N., Buddle B.M. Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection-A review. Vet Immunol Immunopathol 2014, 158:8-13.
27. Parlane N.A., Grage K., Mifune J., Basaraba R.J., Wedlock D.N., Rehm B.H., et al. Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis. Clin Vaccine Immunol 2012, 19:37-44.
28. Rice-Ficht A.C., Arenas-Gamboa A.M., Kahl-McDonagh M.M., Ficht T.A. Polymeric particles in vaccine delivery. Curr Opin Microbiol 2010, 13:106-112.
29. Parlane N.A., Grage K., Lee J.W., Buddle B.M., Denis M., Rehm B.H. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain. Appl Environ Microbiol 2011, 77:8516-8522.
30. Yao Y.C., Zhan X.Y., Zhang J., Zou X.H., Wang Z.H., Xiong Y.C., et al. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands. Biomaterials 2008, 29:4823-4830.
31. Lee J., Jung S.G., Park C.S., Kim H.Y., Batt C.A., Kim Y.R. Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer. Bioorg Med Chem Lett 2011, 21:2941-2944.
32. Xiong Y.C., Yao Y.C., Zhan X.Y., Chen G.Q. Application of polyhydroxyalkanoates nanoparticles as intracellular sustained drug-release vectors. J Biomater Sci Polym Ed 2010, 21:127-140.
33. Kassab A.C., Xu K., Denkbaş E.B., Dou Y., Zhao S., Pişkin E. Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent. J Biomater Sci Polym Ed 1997, 8:947-961.
34. Bayram C., Denkbas E.B., Kiliçay E., Hazer B., Çakmak H.B., Noda I. Preparation and characterization of triamcinolone acetonide-loaded poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHx) microspheres. J Bioact Compat Polym 2008, 23:334-347.
35. Bissery M.C., Valeriote F., Thies C. Fate and effect of CCNU-loaded microspheres made of poly(d, l)lactide (PLA) or poly-β-hydroxybutyrate (PHB) in mice. Proc Int Symp Control Release Bioact Mater 1985, 12:181-182.
36. Heathman T.R., Webb W.R., Han J., Dan Z., Chen G.Q., Forsyth N.R., et al. Controlled production of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) nanoparticles for targeted and sustained drug delivery. J Pharm Sci 2014, 103:2498-2508.
37. Murueva A.V., Shershneva A.M., Shishatskaya E.I., Volova T.G. The use of polymeric microcarriers loaded with anti-inflammatory substances in the therapy of experimental skin wounds. Bull Exp Biol Med 2014, 157:597-602.
38. Kiliçay E., Demirbilek M., Türk M., Güven E., Hazer B., Denkbas E.B. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci 2011, 44:310-320.
39. Dong C.L., Webb W.R., Peng Q., Tang J.Z., Forsyth N.R., Chen G.Q., et al. Sustained PDGF-BB release from PHBHHx loaded nanoparticles in 3D hydrogel/stem cell model. J Biomed Mater Res A 2014, 10.1002/jbm.a.35149.
40. Wu L.P., Wang D., Parhamifar L., Hall A., Chen G.Q., Moghimi S.M. Poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) nanoparticles with polyethylenimine coat as simple, safe, and versatile vehicles for cell targeting: population characteristics, cell uptake, and intracellular trafficking. Adv Healthc Mater 2014, 3:817-824.
41. Peters V., Rehm B.H. In vivo monitoring of PHA granule formation using GFP-labeled PHA synthases. FEMS Microbiol Lett 2005, 248:93-100.
42. Peters V., Becher D., Rehm B.H. The inherent property of polyhydroxyalkanoate synthase to form spherical PHA granules at the cell poles: the core region is required for polar localization. J Biotechnol 2007, 132:238-245.
43. Jahns A.C., Haverkamp R.G., Rehm B.H. Multifunctional inorganic-binding beads self-assembled inside engineered bacteria. Bioconjug Chem 2008, 19:2072-2080.
44. Jahns A.C., Rehm B.H. Tolerance of the Ralstonia eutropha class I polyhydroxyalkanoate synthase for translational fusions to its C terminus reveals a new mode of functional display. Appl Environ Microbiol 2009, 75:5461-5466.
45. Brockelbank J.A., Peters V., Rehm B.H. Recombinant Escherichia coli strain produces a ZZ domain displaying biopolyester granules suitable for immunoglobulin G purification. Appl Environ Microbiol 2006, 72:7394-7397.
46. Peters V., Rehm B.H. Protein engineering of streptavidin for in vivo assembly of streptavidin beads. J Biotechnol 2008, 134:266-274.
47. Banki M.R., Gerngross T.U., Wood D.W. Novel and economical purification of recombinant proteins: intein-mediated protein purification using in vivo polyhydroxybutyrate (PHB) matrix association. Protein Sci 2005, 14:1387-1395.
48. Barnard G.C., McCool J.D., Wood D.W., Gerngross T.U. Integrated recombinant protein expression and purification platform based on Ralstonia eutropha. Appl Environ Microbiol 2005, 71:5735-5742.
49. Wang Z., Wu H., Chen J., Zhang J., Yao Y., Chen G.Q. A novel self-cleaving phasin tag for purification of recombinant proteins based on hydrophobic polyhydroxyalkanoate nanoparticles. Lab Chip 2008, 8:1957-1962.
50. Rasiah I.A., Rehm B.H. One-step production of immobilized alpha-amylase in recombinant Escherichia coli. Appl Environ Microbiol 2009, 75:2012-2016.
51. Mullaney J.A., Rehm B.H. Design of a single-chain multi-enzyme fusion protein establishing the polyhydroxybutyrate biosynthesis pathway. J Biotechnol 2010, 147:31-36.
52. Li Y. Self-cleaving fusion tags for recombinant protein production. Biotechnol Lett 2011, 33:869-881.
53. Leong Y.K., Show P.L., Ooi C.W., Ling T.C., Lan J.C. Current trends in polyhydroxyalkanoates (PHAs) biosynthesis: insights from the recombinant Escherichia coli. J Biotechnol 2014, 180:52-65.
54. Rehm B.H. Biogenesis of microbial polyhydroxyalkanoate granules: a platform technology for the production of tailor-made bioparticles. Curr Issues Mol Biol 2007, 9:41-62.
55. Furrer P., Panke S., Zinn M. Efficient recovery of low endotoxin medium-chain-length poly([R]-3-hydroxyalkanoate) from bacterial biomass. J Microbiol Methods 2007, 69:206-213.
56. Rehm B.H. Bacterial polymers: biosynthesis, modifications and applications. Nat Rev Microbiol 2010, 8:578-592.
57. Nogales J., Palsson B.Ø., Thiele I. A genome-scale metabolic reconstruction of Pseudomonas putida KT2440: iJN746 as a cell factory. BMC Syst Biol 2008, 2:79. 10.1186/1752-0509-2-79.
58. Maestro B., Galán B., Alfonso C., Rivas G., Prieto M.A., Sanz J.M. A new family of intrinsically disordered proteins: structural characterization of the major phasin PhaF from Pseudomonas putida KT2440. PLoS One 2013, 8:e56904.
59. Ihssen J., Magnani D., Thöny-Meyer L., Ren Q. Use of extracellular medium chain length polyhydroxyalkanoate depolymerase for targeted binding of proteins to artificial poly[(3-hydroxyoctanoate)-co-(3-hydroxyhexanoate)] granules. Biomacromolecules 2009, 10:1854-1864.
60. Park T.J., Yoo S.M., Keum K.C., Lee S.Y. Microarray of DNA-protein complexes on poly-3-hydroxybutyrate surface for pathogen detection. Anal Bioanal Chem 2009, 393:1639-1647.
61. Muniasamy G., Pérez-Guevara F. Use of SNAREs for the immobilization of poly-3-hydroxyalkanoate polymerase type II of Pseudomonas putida CA-3 in secretory vesicles of Saccharomyces cerevisiae ATCC 9763. J Biotechnol 2014, 172:77-79.
62. Hooks D.O., Blatchford P.A., Rehm B.H. Bioengineering of bacterial polymer inclusions catalyzing the synthesis of N-acetylneuraminic acid. Appl Environ Microbiol 2013, 79:3116-3121.
63. McCool G.J., Cannon M.C. PhaC and PhaR are required for polyhydroxyalkanoic acid synthase activity in Bacillus megaterium. J Bacteriol 2001, 183:4235-4243.
64. Molino N.M., Wang S.-W. Caged protein nanoparticles for drug delivery. Curr Opin Biotechnol 2014, 28:75-82.
65. Steinmann B., Christmann A., Heiseler T., Fritz J., Kolmar H. In vivo enzyme immobilization by inclusion body display. Appl Environ Microbiol 2010, 76:5563-5569.
66. Kim H.N., Lee J., Kim H.Y., Kim Y.R. Enzymatic synthesis of a drug delivery system based on polyhydroxyalkanoate-protein block copolymers. Chem Commun (Camb) 2009, 46:7104-7106.
67. Grage K., Peters V., Rehm B.H. Recombinant protein production by in vivo polymer inclusion display. Appl Environ Microbiol 2011, 77:6706-6709.
68. Geng Y., Wang S., Qi Q. Expression of active recombinant human tissue-type plasminogen activator by using in vivo polyhydroxybutyrate granule display. Appl Environ Microbiol 2010, 76:7226-7230.
69. Chen G.Q., Whang Z.G. A method and kit for purification of recombinant proteins using self-cleaving protein intein 2011, [PTC/CN2008/001006].
70. Kim D.Y., Kim H.C., Kim S.Y., Rhee Y.H. Molecular characterization of extracellular medium-chain-length poly(3-hydroxyalkanoate) depolymerase genes from Pseudomonas alcaligenes strains. J Microbiol 2005, 43:285-294.
71. Prieto M.A., de Eugenio L.I., Galán B., Luengo J.M., Witholt B. Pseudomonas: a model system in biology. Pseudomonas 2007, vol. V. Springer. J.L. Ramos, A. Filloux (Eds.).
72. Ouyang S.P., Luo R.C., Chen S.S., Liu Q., Chung A., Wu Q., et al. Production of polyhydroxyalkanoates with high 3-hydroxydodecanoate monomer content by fadB and fadA knockout mutant of Pseudomonas putida KT2442. Biomacromolecules 2007, 8:2504-2511.
73. Qi Q., Steinbüchel A., Rehm B.H. Metabolic routing towards polyhydroxyalkanoic acid synthesis in recombinant Escherichia coli (fadR): inhibition of fatty acid beta-oxidation by acrylic acid. FEMS Microbiol Lett 1998, 167:89-94.
74. Lu X.Y., Wu Q., Zhang W.J., Zhang G., Chen G.Q. Molecular cloning of polyhydroxyalkanoate synthesis operon from Aeromonas hydrophila and its expression in Escherichia coli. Biotechnol Prog 2004, 20:1332-1336.
75. Tsuge T., Taguchi K., Seiichi T., Doi Y. Molecular characterization and properties of (R)-specific enoyl-CoA hydratases from Pseudomonas aeruginosa: metabolic tools for synthesis of polyhydroxyalkanoates via fatty acid beta-oxidation. Int J Biol Macromol 2003, 31:195-205.
76. Nomura C.T., Taguchi K., Gan Z., Kuwabara K., Tanaka T., Takase K., et al. Expression of 3-ketoacyl-acyl carrier protein reductase (fabG) genes enhances production of polyhydroxyalkanoate copolymer from glucose in recombinant Escherichia coli JM109. Appl Environ Microbiol 2005, 71:4297-4306.
77. Langenbach S., Rehm B.H., Steinbüchel A. Functional expression of the PHA synthase gene phaC1 from Pseudomonas aeruginosa in Escherichia coli results in poly(3-hydroxyalkanoate) synthesis. FEMS Microbiol Lett 1997, 150:303-309.
78. Gasser B., Saloheimo M., Rinas U., Dragosits M., Rodríguez-Carmona E., Baumann K., et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008, 7:11.
79. Poblete-Castro I., Becker J., Dohnt K., dos Santos V.M., Wittmann C. Industrial biotechnology of Pseudomonas putida and related species. Appl Microbiol Biotechnol 2012, 93:2279-2290.
80. Poblete-Castro I., Escapa I.F., Jäger C., Puchalka J., Lam C.M., Schomburg D., et al. The metabolic response of P. putida KT2442 producing high levels of polyhydroxyalkanoate under single- and multiple-nutrient-limited growth: highlights from a multi-level omics approach. Microb Cell Fact 2012, 11:34. 10.1186/1475-2859-11-34.
81. Poblete-Castro I., Binger D., Rodrigues A., Becker J., Martins Dos Santos V.A., Wittmann C. In-silico-driven metabolic engineering of Pseudomonas putida for enhanced production of poly-hydroxyalkanoates. C Metab Eng 2013, 15:113-123.
82. Follonier S., Escapa I.F., Fonseca P.M., Henes B., Panke S., Zinn M., et al. New insights on the reorganization of gene transcription in Pseudomonas putida KT2440 at elevated pressure. Microb Cell Fact 2013, 12:30. 10.1186/1475-2859-12-30.
83. Escapa I.F., García J.L., Bühler B., Blank L.M., Prieto M.A. The polyhydroxyalkanoate metabolism controls carbon and energy spillage in Pseudomonas putida. Environ Microbiol 2012, 14:1049-1063.
84. Silva-Rocha R., Martínez-García E., Calles B., Chavarría M., Arce-Rodríguez A., de Las Heras A., et al. The Standard European Vector Architecture (SEVA): a coherent platform for the analysis and deployment of complex prokaryotic phenotypes. Nucleic Acids Res 2013, 41:D666-D675.
85. Martínez V., García P., García J.L., Prieto M.A. Controlled autolysis facilitates the polyhydroxyalkanoate recovery in Pseudomonas putida KT2440. Microb Biotechnol 2011, 4:533-547.
86. Rehm B.H., Steinbüchel A. Biochemical and genetic analysis of PHA synthases and other proteins required for PHA synthesis. Int J Biol Macromol 1999, 25:3-19.
87. Pfeiffer D., Wahl A., Jendrossek D. Identification of a multifunctional protein, PhaM, that determines number, surface to volume ratio, subcellular localization and distribution to daughter cells of poly(3-hydroxybutyrate), PHB, granules in Ralstonia eutropha H16. Mol Microbiol 2011, 82:936-951.
88. Pfeiffer D., Jendrossek D. PhaM Is the physiological activator of poly(3-hydroxybutyrate) (PHB) synthase (PhaC1) in Ralstonia eutropha. Appl Environ Microbiol 2014, 80:555-563.
89. Stubbe J., Tian J. Polyhydroxyalkanoate (PHA) hemeostasis: the role of PHA synthase. Nat Prod Rep 2003, 20:445-457.
90. Pfeiffer D., Jendrossek D. Interaction between poly(3-hydroxybutyrate) granule-associated proteins as revealed by two-hybrid analysis and identification of a new phasin in Ralstonia eutropha H16. Microbiology 2011, 157:2795-2807.
91. Dennis D., Sein V., Martinez E., Augustine B. PhaP is involved in the formation of a network on the surface of polyhydroxyalkanoate inclusions in Cupriavidus necator H16. J Bacteriol 2008, 190:555-563.
92. Prieto M.A., Buehler B., Jung K., Witholt B., Kessler B. PhaF, a polyhydroxyalkanoate-granule-associated protein of Pseudomonas oleovorans GPo1 involved in the regulatory expression system for pha genes. J Bacteriol 1999, 181:858-868.
93. Wahl A., Schuth N., Pfeiffer D., Nussberger S., Jendrossek D. PHB granules are attached to the nucleoid via PhaM in Ralstonia eutropha. BMC Microbiol 2012, 12:262.
94. Neumann L., Spinozzi F., Sinibaldi R., Rustichelli F., Pötter M., Steinbüchel A. Binding of the major phasin, PhaP1, from Ralstonia eutropha H16 to poly(3-hydroxybutyrate) granules. J Bacteriol 2008, 190:2911-2919.
95. Opal S.M. Endotoxemia and endotoxin shock: disease, diagnosis and therapy. Contrib Nephrol 2010, vol. 167:14-24. Karger, Basel. C. Ronco, P. Piccinni, M.H. Rosner (Eds.).
96. Chen G.Q., Wu Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 2005, 26:6565-6578.
97. Valappil S.P., Misra S.K., Boccaccini A.R., Roy I. Biomedical applications of polyhydroxyalkanoates: an overview of animal testing and in vivo responses. Expert Rev Med Devices 2006, 3:853-868.
98. Lee S.Y., Choi J., Han K., Song J.Y. Removal of endotoxin during purification of poly(3-hydroxybutyrate) from gram-negative bacteria. Appl Environ Microbiol 1999, 65:2762-2764.
99. FDA Guideline on validation of the Limulus amebocyte lysate test as an end-product endotoxin test for human an animal parenteral drugs, biological products, and medical devices 1987, [Rockville, MD. http://www.gmpua.com/Validation/Method/LAL/FDAGuidelineForTheValidationA.pdf]. U.S. Department of Health and Human Services FaDA (Ed.).
100. Valappil S.P., Boccaccini A.R., Bucke C., Roy I. Polyhydroxyalkanoates in Gram-positive bacteria: insights from the genera Bacillus and Streptomyces. Antonie Van Leeuwenhoek 2007, 91:1-17.
101. Declue A.E., Johnson P.J., Day J.L., Amorim J.R., Honaker A.R. Pathogen associated molecular pattern motifs from Gram-positive and Gram-negative bacteria induce different inflammatory mediator profiles in equine blood. Vet J 2012, 192:455-460.
102. Sutcliffe I.C. The lipoteichoic acids and lipoglycans of gram-positive bacteria: a chemotaxonomic perspective. Syst Appl Microbiol 1994, 17:467-480.
103. Iwasaki H., Shimada A., Yokoyama K., Ito E. Structure and glycosylation of lipoteichoic acids in Bacillus strains. J Bacteriol 1989, 171:424-429.
104. Sutcliffe I.C., Shaw N. Atypical lipoteichoic acids of gram-positive bacteria. J Bacteriol 1991, 173:7065-7069.
105. Haywood G.W., Anderson A.J., Williams D.R., Dawes E.A., Ewing D.F. Accumulation of a poly(hydroxyalkanoate) copolymer containing primarily 3-hydroxyvalerate from simple carbohydrate substrates by Rhodococcus sp. NCIMB 40126. Int J Biol Macromol 1991, 13:83-88.
106. Alvarez H.M., Kalscheuer R., Steinbüchel A. Accumulation and mobilization of storage lipids by Rhodococcus opacus PD630 and Rhodococcus ruber NCIMB 40126. Appl Microbiol Biotechnol 2000, 54:218-223.
107. Chen G.Q., König K.H., Lafferty R.M. Production of poly-D(-)-3-hydroxybutyrate and poly-D(-)-3-hydroxyvalerate by strains of Alcaligenes latus. Antonie Van Leeuwenhoek 1991, 60:61-66.
108. Li J., Shang G., You M., Peng S., Wang Z., Wu H., et al. Endotoxin removing method based on lipopolysaccharide binding protein and polyhydroxyalkanoate binding protein PhaP. Biomacromolecules 2011, 12:602-608.
109. Wiggam M.I., O'Kane M.J., Harper R., Atkinson A.B., Hadden D.R., Trimble E.R., et al. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Diabetes Care 1997, 20:1347-1352.
110. Reusch R.N. Transmembrane ion transport by polyphosphate/poly-(R)-3-hydroxybutyrate complexes. Biochemistry (Mosc) 2000, 65:280-295.
111. You M., Peng G., Li J., Ma P., Wang Z., Shu W., et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials 2011, 32:2305-2313.
112. Xie H., Li J., Li L., Dong Y., Chen G.Q., Chen K.C. Enhanced proliferation and differentiation of neural stem cells grown on PHA films coated with recombinant fusion proteins. Acta Biomater 2013, 9:7845-7854.
113. Dong Y., Li P., Chen C.B., Wang Z.H., Ma P., Chen G.Q. The improvement of fibroblast growth on hydrophobic biopolyesters by coating with polyhydroxyalkanoate granule binding protein PhaP fused with cell adhesion motif RGD. Biomaterials 2010, 31:8921-8930.
114. Rosenthal J.A., Chen L., Baker J.L., Putnam D., DeLisa M.P. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. Curr Opin Biotechnol 2014, 28:51-58.
115. Newman K.D., Samuel J., Kwon G. Ovalbumin peptide encapsulated in poly(d, l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. J Control Release 1998, 54:49-59.
116. Singh M., Chakrapani A., O'Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev Vaccines 2007, 6:797-808.
117. Mestas J., Hughes C.C.W. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
118. Roep B.O., Atkinson M. Animal models have little to teach us about type 1 diabetes: 1. In support of this proposal. Diabetologia 2004, 47:1650-1656.
119. Elustondo P., Zakharian E., Pavlov E. Identification of the polyhydroxybutyrate granules in mammalian cultured cells. Chem Biodivers 2012, 9:2597-2604.
120. Pavlov E., Zakharian E., Bladen C., Diao C.T., Grimbly C., Reusch R.N., et al. A large, voltage-dependent channel, isolated from mitochondria by water-free chloroform extraction. Biophys J 2005, 88:2614-2625.
121. Reusch R.N. Low molecular weight complexed poly(3-hydroxybutyrate): a dynamic and versatile molecule in vivo. Can J Microbiol 1995, 41:50-54.
122. Reusch R.N., Shabalin O., Crumbaugh A., Wagner R., Schröder O., Wurm R. Posttranslational modification of E. coli histone-like protein H-NS and bovine histones by short-chain poly-(R)-3-hydroxybutyrate (cPHB). FEBS Lett 2002, 527:319-322.
123. Negoda A., Xian M., Reusch R.N. Insight into the selectivity and gating functions of Streptomyces lividans KcsA. Proc Natl Acad Sci U S A 2007, 104:4342-4346.
124. Reusch R.N. Poly-beta-hydroxybutyrate/calcium polyphosphate complexes in eukaryotic membranes. Proc Soc Exp Biol Med 1989, 191:377-381.
125. Seebach D., Brunner A., Bürger H.M., Schneider J., Reusch R.N. Isolation and 1H-NMR spectroscopic identification of poly(3-hydroxybutanoate) from prokaryotic and eukaryotic organisms. Determination of the absolute configuration (R) of the monomeric unit 3-hydroxybutanoic acid from Escherichia coli and spinach. Eur J Biochem 1994, 224:317-328.
126. Zakharian E., Thyagarajan B., French R.J., Pavlov E., Rohacs T. Inorganic polyphosphate modulates TRPM8 channels. PLoS One 2009, 4(4):e5404. 10.1371/journal.pone.0005404.
127. Gomes M.E., Reis R.L. Biodegradable polymers and composites in biomedical applications: from catgut to tissue engineering. Part 1. Available systems and their properties. Int Mater Rev 2004, 49:261-273.
128. Bala I., Hariharan S., Kumar M.N. PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2004, 21:387-422.
129. Mohanraj V.J., Chen Y. Nanoparticles-a review. Trop J Pharm Res 2006, 5:561-573.
130. Hazer D.B., Kiliçay E., Hazer B. Poly(3-hydroxyalkanoate)s: diversification and biomedical applications. A state of the art review. Mater Sci Eng C 2012, 32:637-647.
131. Türesin F., Gürsel I., Hasirci V. Biodegradable polyhydroxyalkanoate implants for osteomyelitis therapy: in vitro antibiotic release. J Biomater Sci Polym Ed 2001, 12:195-207.
132. Wang Y., Yin J., Chen G.Q. Polyhydroxyalkanoates, challenges and opportunities. Curr Opin Biotechnol 2014, 30C:59-65.
133. Danhier F., Ansorena E., Silva J.M., Coco R., Le Breton A., Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 2012, 161:505-522.
134. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001, 70:1-20.
135. Philip S., Keshavarz T., Roy I. Polyhydroxyalkanoates: biodegradable polymers with a range of applications. J Chem Technol Biotechnol 2007, 82:233-247.
136. Park H., Yang J., Seo S., Kim K., Suh J., Kim D., et al. Multifunctional nanoparticles for photothermally controlled drug delivery and magnetic resonance imaging enhancement. Small 2008, 4:192-196.
137. Kim J., Lee E.J., Lee S.H., Yu J.H., Lee J.H., Park T.G., et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv Mater 2008, 20:478-483.
138. Lü J.M., Wang X., Marin-Muller C., Wang H., Lin P.H., Yao Q., et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 2009, 9:325-341.
139. Bordes P., Pollet E., Avérous L. Nano-biocomposites: biodegradable polyester/nanoclay systems. Prog Polym Sci 2009, 34:125-155.
140. Avérous L., Pollet E. Green nano-biocomposites. Environmental silicate nano-biocomposites, green energy and technology 2012, Springer-Verlag, London. 10.1007/978-1-4471-4108-2_1. L. Avérous, E. Pollet (Eds.).
141. Akaraonye E., Keshavarz T., Roy I. Production of polyhydroxyalkanoates: the future green materials of choice. J Chem Technol Biotechnol 2010, 85:732-743.